Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

Discover how pre-stratification enables you to reduce clinical trial size without sacrificing statistical power.

Non-inferiority trials are a valuable type of clinical trial to evaluate new treatments that might have differing benefits. Such trials are increasingly used, but have methodological challenges in ...

With various challenges impacting the clinical supply chain, existing models are no longer fit-for-purpose and need to adapt.

Clinical trials are the cornerstone of drug innovation in modern medicine, providing a systematic, evidence-based framework for determining the efficacy and safety of treatments before they reach ...

Photo-Illustration by Chloe Dowling for TIME (Source Images: Maki Nakamura—Getty Images, Tara Moore—Getty Images, We Are/Getty Images, Leland Bobbe—Getty Images, Willie B. Thomas—Getty Images, Morsa ...

GCCL Co., Ltd. (GCCL), a data-driven clinical trial services provider, and Medicover Integrated Clinical Services (MICS), part of Medicover, an international healthcare and diagnostic services company ...

U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of ...

In addition to improving payment speed, accuracy, and transparency, modern payment technology is creating new opportunities to further improve the trial experience. For example, AI is being used to ...

Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly’s optimistically dubbed family of Triumph trials—to the downright ostentatious, like ...